 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareAnemia & HIV/AIDS
See also: Fatigue & HIV/AIDS
Overview
- A Clinical Overview of Epoetin Alfa (Epogen, Procrit) (March 22, 2007)
From AIDSinfo - Challenging Cases in HIV: Implications of Anemia (November 29, 2006)
A slide presentation with audio of a case-study by David H. Henry, M.D., reviewing the incidence and impact of anemia in HIV-infected patients; to view only the slides, without the audio, click here.
From The Body PRO - Challenging Cases in HIV: Implications of Anemia (November 29, 2006)
A slide presentation with audio of a case-study by Douglas T. Dieterich, M.D., reviewing the incidence and impact of anemia in HIV-infected patients; to view only the slides, without the audio, click here.
From The Body PRO - Longer Dosing Intervals of Epoetin Alfa Are Effective in Maintaining Hemoglobin Levels in Anemic, HIV-Infected Patients (September 17, 2003)
[Archived Article]
In The 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, from The Body PRO - Hydroxyurea in the Treatment of HIV-1 (January 2000)
In Annals of Pharmacotherapy
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.